An In Vitro Intact Globe Expansion Method for Evaluation of Cross-linking Treatments by Mattson, Matthew S. et al.
An In Vitro Intact Globe Expansion Method for
Evaluation of Cross-linking Treatments
Matthew S. Mattson,1,2 Joyce Huynh,3 Meredith Wiseman,3 Marco Coassin,2
Julia A. Kornfield,*,3 and Daniel M. Schwartz*,2
PURPOSE. To measure the tissue mechanical response to ele-
vated intraocular pressure (IOP) using intact globe expansion
of rabbit eyes. This method examined rabbit kit (2–3 weeks
old) eyes as a model for weakened tissue and evaluated ribo-
flavin/UVA and glyceraldehyde cross-linking treatments.
METHODS. The ocular shape of enucleated eyes was photo-
graphed during a 24-hour period while a controlled IOP was
imposed (either low IOP  22 mm Hg or high IOP  85 mm
Hg). Untreated controls consisted of kit eyes tested at both
low- and high IOP and adult eyes tested at high IOP. Treated kit
eyes (dextran controls, riboflavin/UVA treatment of the cornea,
and glyceraldehyde treatment of the entire globe) were tested
at high IOP.
RESULTS. Low IOP elicited negligible creep of the sclera and
very gradual creep of the cornea. In contrast, high IOP induced
up to an 8% strain in the sclera and a 15% strain in the cornea
of rabbit kit eyes. The expansion of adult eyes was less than
one third that of kit eyes at the same, high IOP. Riboflavin/UVA
treatment of corneas reduced expansion compared with that in
both dextran-treated and untreated control corneas. Glyceral-
dehyde treatment prevented expansion of the cornea and
sclera.
CONCLUSIONS. The intact globe expansion method (GEM) im-
poses a loading geometry comparable to in vivo conditions and
can quantify changes in mechanical stability as a function of
testing conditions (e.g., IOP, tissue maturation, and therapeu-
tic cross-linking) with small sample sizes and small variability.
Rabbit kit eyes provide a model of weak tissue suitable for
screening treatments that strengthen the cornea and sclera.
(Invest Ophthalmol Vis Sci. 2010;51:3120–3128) DOI:
10.1167/iovs.09-4001
There is currently a high level of interest in strengtheningthe ocular coat (i.e., cornea and sclera). Diseases such as
keratoconus and degenerative myopia lead to progressive vi-
sual loss due to inadequate mechanical stability of the cornea
and sclera.1–3 In these diseases, changes in the biochemistry of
the tissue (altered types and concentrations of enzymes, pro-
teoglycans, and collagen) coincide with macroscopic structural
changes (thinning, weakening, and increased susceptibility to
deformation).4–6 To stabilize the shape of the globe, Wollen-
sak et al.7 have pioneered the use of riboflavin and ultraviolet
light (UVA) to cross-link collagen and enhance the mechanical
properties of the tissue. This method shows promise for treat-
ment of keratoconus8 and other cross-linking approaches (e.g.,
glyceraldehyde and nitroalcohols) may provide stabilization of
scleral shape in progressive myopia9–11 or strengthening of
peripapillary sclera in glaucoma.12
The effects of treatments on the strength of the cornea and
sclera are manifested in the change in the rate and extent of
deformation of the globe under the influence of intraocular
pressure. Therefore, it is desirable to develop in vitro methods
to quantitatively evaluate the change in mechanical stability
due to treatment. Previously, researchers evaluating tissue me-
chanics have relied on methods such as tensile tests,13–17
button tests,18,19 and intact globe tests.20–23 The majority of
work evaluating riboflavin/UVA and other cross-linking treat-
ments has been done with tensile measurements (Spoerl E, et
al. IOVS 1999;40:ARVO Abstract 1800).24–26 The tensile testing
method is well established in biomechanics, but researchers
have acknowledged problems. As summarized by Greene and
McMahon,20 “Uniaxial stress-strain tests on a soft biological
material such as sclera are plagued with many problems. First,
the sample must be cut from the sclera, thus fraying the
collagen fibrils at the edges of the sample. The mechanical
effect of this procedure is difficult to assess, but it almost
certainly weakens the sample. Second, the sample is initially
curved, and must be unbent for the purpose of the uniaxial
test. This unavoidably gives rise to a distribution of positive and
negative stresses across the thickness of the sample, a situation
quite different from the in vivo state of affairs. Third, the
sample must be clamped in the jaws of a vise, thus giving rise
to very large compressive stresses at the ends of the sample.
Slippage at the jaws could easily be mistaken for plastic defor-
mation or creep of the sample. Lastly, the normal state of stress
in the sclera is biaxial, not uniaxial.” Ideally, a testing method
to quantify changes in mechanical stability of the ocular coat
would be repeatable with little variability, would be applicable
to healthy or diseased tissue, and would mimic in vivo condi-
tions. Significant features of the mechanics in vivo are biaxial
loading due to a pressure difference between the interior and
exterior of the globe, low total strain, and very low strain rates.
Indeed, the therapeutic benefit of proposed treatments de-
pends on their efficacy at low strain, particularly in preventing
gradual creep (i.e., time-dependent extension under a constant
load). A testing method capable of addressing these problems
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may enable the in vivo effects of therapeutic agents to be
anticipated by in vitro assays, providing a tool for optimizing
treatments.
We used the sensitivity of a new apparatus, together with a
model of weakened cornea and sclera to enable in vitro, quan-
titative comparison of treatments that alter the mechanical
stability of ocular tissues. Specifically, we devised an intact
globe expansion apparatus that enables the study and quanti-
fication of a whole eye’s ability to resist deformation while
subjected to elevated intraocular pressure (IOP). In relation to
diseases, rabbit kit (2–3 weeks old) eyes were examined as a
suitable model for weak tissue that exhibits a propensity to
deform under constant IOP. Together, the expansion appara-
tus and kit eyes were evaluated as a tool for determining the
efficacy of possible treatments. Specifically, riboflavin/UVA-
treated tissue was readily distinguishable from both untreated
(negative) controls and glyceraldehyde cross-linked (positive)
controls even at small strain (10%) and extremely slow strain
rates (0.01%/min).
METHODS
Tissue Specimens and In Vitro
Treatment Protocols
Enucleated eyes from New Zealand White rabbits were used. Rabbits of
different sex were included randomly. Two distinct age groups were
examined. Enucleated eyes from young rabbit kits (2–3 weeks old,
0.75–1.0 kg) were provided by Keith Duncan (University of California,
San Francisco). Within 3 hours of enucleation, the eyes were shipped
in isotonic saline on ice. Enucleated eyes from adult New Zealand
White rabbits (6 months old, 2.7 kg) were purchased from Pel-
Freez Arkansas, LLC (Rogers, AR). Prior studies confirmed that the
epithelium was intact after shipping (application of 2% fluorescein
drops failed to stain the corneal collagen).
On receipt, the eyes were stored in saline on ice until used, not
sooner than 24 or later than 48 hours after enucleation. The fat and
muscle were removed from all eyes with scissors to expose the sclera.
A smooth ocular surface provided a well-defined perimeter in the
images. Thirty-five eyes were used: 8 from adult rabbits and 27 from
rabbit kits. The number of eyes for each protocol is indicated in the
Results section.
Riboflavin/UVA. Pairs of enucleated eyes from five rabbit kits
were used to study riboflavin/UVA treatment according to the proce-
dures outlined in Wollensak et al.24 Briefly, the epithelium was re-
moved by scraping the corneal surface with a scalpel blade, and then
drops of treatment solution containing 0.1% riboflavin-5-monophos-
phate (Sigma-Aldrich, St. Louis, MO) in 20% dextran T500 (Pharmacos-
mos, Holbaek, Denmark) were applied to the cornea for 5 minutes
followed by 30 minutes of UVA exposure (370 nm, 3 mW/cm2, eval-
uated with a 55PM Laser Power Meter; Liconix, Santa Clara, CA) with
additional drops every 5 minutes. The light source built in our labora-
tory consisted of an array of seven LEDs (Roithner LaserTechnik,
Vienna, Austria) located 2 cm from the cornea. Fellow eyes with the
epithelium removed were used as the control; they received 20%
dextran without riboflavin with drop application and irradiation as just
described. After irradiation, each eye was rinsed in 10 mL of Dulbec-
co’s phosphate-buffered saline (DPBS; D8662, 274–303 mOsm/kg;
Sigma-Aldrich) solution for 30 minutes and then loaded into the intact
globe expansion apparatus.
Glyceraldehyde. Six rabbit kit eyes were used to establish the
effect of glyceraldehyde cross-linking. The epithelium was removed
with a scalpel blade, and whole eyes were soaked in 2% DL-glyceralde-
hyde (Sigma-Aldrich) in DPBS for 12 hours. The eyes were then placed
in a DPBS bath for 12 hours to rinse off excess glyceraldehyde. Dext-
ran-treated and untreated kits eyes were used as control samples.
Experimental Apparatus and Measurements
Intact globe expansion measurements were made in a transparent
Plexiglas observation cell (Fig. 1). The bottom of the observation cell
had two holes sealed with rubber septa, used for the insertion of
hypodermic needles (30-gauge) to regulate the IOP. The pressure
imposed through the needles was achieved with a DPBS reservoir held
at a corresponding height (h) above the apparatus, imposing an IOP
equal to the hydrostatic pressure (IOP  gh, where  is density and
g is gravitational acceleration). Before the globes were mounted, the
integrity of the fluid path was confirmed by briefly opening the valve
to observe fluid flow from the reservoir through the needle. To ensure
that the hydrostatic pressure was indeed the IOP in the globe, it was
necessary to minimize leakage of fluid from the eyes that could result
in a pressure drop across the needle. Therefore, small-diameter needles
were used to minimize the risk of a leak around the needle after the
sclera was pierced. The apparatus makes it immediately obvious when
a leak occurs: changes in fluid level in the sample chamber are readily
observed and are recorded in the sequence of images. Of the experi-
ments reported herein, three fourths had no detectable leak, and one
fourth had detectable but very gradual leaks (bath fluid level rose 0.3
mm/h, corresponding to a volumetric flow rate of 0.9 mL/h, and
perturbing the imposed IOP by 2%). There was no rupture of the
eyes within the 24 hours allocated to this experiment.
After specimen preparation, two enucleated eyes were loaded onto
transparent acrylic cylinders in the DPBS bath (Fig. 1A). Because the
tissues of interest are anisotropic and the eye is not symmetric, a
consistent orientation was used; the eyes were aligned with the optical
axis vertical, with the major axis of the equator parallel to the imaging
plane, and with the optic nerve on the side closest to the camera. The
eyes were nearly neutrally buoyant in the bath solution; therefore,
loading was performed with the bath partially filled (fluid level slightly
above the cylinder height), so that the weight of the eyes facilitated
orienting the globes. The needles were then inserted through the
posterior sclera. After insertion, friction between the needle and tissue
FIGURE 1. (A) Apparatus for control-
ling IOP during intact globe expansion
experiments. (Not to scale: The eye is
approximately 14 cm in diameter, and
the height of the reservoir ranges from
30 to 116 cm.) The height of the saline
reservoir generates a hydrostatic pres-
sure that is transferred to the eye
through the hypodermic needle on
opening the valve. A bath of DPBS
maintains the equilibrated extent of
hydration of the tissue. Digital photo-
graphs are taken throughout the 24
hours of testing. (B) Ocular dimen-
sions are measured with a program
written in commercial software (Mat-
Lab; The MathWorks, Natick, MA).
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was sufficient to hold the eyes in place without other methods of fixing
the position. The bath was then filled with DPBS to maintain the state
of hydration of the tissues. To minimize bacterial growth during the
experiment, we added several antibiotic eye drops (neomycin, poly-
myxin B sulfate and gramicidin ophthalmic solution USP; Bausch &
Lomb, Tampa, FL) to the solution in the observation cell. The eyes
were allowed 15 minutes to reach bath temperature (22°C) before
the valve was opened, and an IOP similar to the physiological state was
reintroduced (see the Shape Restoration section). For creep experi-
ments, the pressure was subsequently increased from low IOP to high
IOP (see the Creep section).
Initially, experiments were performed by recording photographs
from three orthogonal directions: along the optical axis of the globe
and two projections orthogonal to the optical axis (in the plane of the
major equatorial axis and in the plane of the minor equatorial axis). All
three projections gave consistent results for the change of the perim-
eter of the sclera; and the two projections orthogonal to the optical
axis gave consistent results for the change of the perimeter of the
cornea. Therefore, a simplified method using a single projection or-
thogonal to the optical axis was adopted; specifically, the plane con-
taining the optical axis and the major equatorial axis was chosen to
characterize relative changes in eye shape for this article. Digital
photographs of this projection were taken automatically every 15
minutes (PowerShot G3; Canon, Tokyo, Japan). A time series of images
offers advantages over relying on initial and final photographs, such as
permitting sensitive detection of leaks; tracking of anatomic features,
such as the corneal–scleral intersection at the limbus; and evaluating
changes in creep rates over the course of the experiment.
The images were analyzed to evaluate changes in ocular dimen-
sions using a computer program written by one of the authors (MSM;
MatLab; The MathWorks, Natick, MA). The code allows the user to
select points along the perimeter of the eye defining the boundary of
the cornea and sclera and uses cubic spline interpolation to trace the
outline of the eye. Using the traces, we computed three measures of
the sclera (scleral perimeter, SP; equatorial diameter, ED; and scleral
length, SL) and three measures of the cornea: corneal perimeter, CP;
corneal diameter, CD; and corneal length, CL (Fig. 1B). The ratios of
the scleral and corneal perimeters at time t to their respective values at
time 0, SP(t)/SP(0) and CP(t)/CP(0), are analogous to strain measure-
ments in tensile tests. The corneal and scleral lengths are similar to the
axial length measurements typical in biometry. The acrylic cylinders of
known diameter (12.7 mm) provided a scale inside the bath for
calibration of pixels to millimeters in each image sequence.
Uncertainty in the measured length ratios is small and predomi-
nantly due to animal-to-animal variability. Three potential sources of
uncertainty are (1) inaccuracy of point placement during image anal-
ysis, (2) image distortion through the bath and the camera optics, and
(3) errors in calibration. The first two were evaluated using images of
grids with known line spacing placed in the DPBS bath. First, to
characterize the uncertainty in point placement during image analysis,
we performed repeat placement of points along a 1-mm line. Repeat-
ability was good to the nearest pixel (SD 0.25 pixel); the resulting
uncertainty in the measured length ratios was an order of magnitude
less than the observed experimental uncertainty (e.g., for a 15% in-
crease in CP(t)/CP(0), point placement accounts for 0.015% uncer-
tainty, whereas the overall experimental uncertainty is 2%). Second,
the images of the uniform grid were used to characterize distortion
resulting from refraction at the air–bath interface and from the optics
of the low-cost cameras that were used for the experiments. The
number of pixels per millimeter interval on the grid varied 3% from
intervals near the center of a specimen to intervals near their perime-
ter. This image distortion has very little effect on the measured length
ratio, since it affects the numerator and denominator almost identically
(e.g., for a 15% increase in CP(t)/CP(0), the resulting error is 0.03%).
Since the actual uncertainty due to animal-to-animal variability is ap-
proximately 10-fold greater, no benefit could be gained by improving
the resolution of the camera or the quality of the lenses, or by imple-
menting correction factors for refraction at the air–bath interface. Last,
although uncertainty in the calibration of pixels per millimeter has no
effect on the measured length ratios, it is characterized for complete-
ness. From uncertainty in measuring the acrylic cylinder diameter, the
number of micrometers/pixel was found to vary up to 0.3% (i.e., 0.1
m/pixel of 28 m/pixel).
Experimental Protocol
Shape Restoration. Enucleated eyes are not stabilized by phys-
iological IOP, and so handling them during shipping, removing fat and
muscle from their surface, and mounting the globes results in a variable
shape. Normal IOP in rabbits is known to fluctuate throughout the day
(lowest, 12.6  0.5 mm Hg; highest, 17.6  1.3 mm Hg).27 In an effort
to reverse the effects of handling, an IOP slightly above the physiolog-
ical state (22 mm Hg) was imposed for 1 hour. Ocular dimensions
measured at the end of this 1-hour restoration period were taken as the
initial state of the eye for all other experiments.
Creep Measurements. The slow, time-dependent deformation
of a sample subjected to a constant applied stress is referred to as
creep, which has particular relevance to the cornea and sclera, as they
are continually subjected to IOP. Despite their nonuniform thickness,
nonuniform curvature, and nonuniform mechanical properties, the
cornea and sclera in an intact globe geometry exhibit reproducible
nominal creep rates under the influence of a constant, elevated IOP.
For simplicity, we refer to the observed “nominal creep” as creep.
Analogous to strain, nominal creep is expressed as a change in length
divided by an initial length.
The effect of imposed IOP was examined in rabbit kit eyes with
intact epithelium. After loading and shape restoration, five eyes were
maintained at low IOP (22 mm Hg) and six eyes were subjected to high
IOP (85 mm Hg) for 23 hours.
To examine the effect of tissue maturation, we used eight adult
rabbit eyes with intact epithelium. After loading and shape restoration,
the eyes were subjected to high IOP for 23 hours.
The effect of riboflavin/UVA treatment of the cornea was examined
relative to negative (untreated and dextran) and positive (glyceralde-
hyde treated) controls. Specimens were loaded after receiving the in
vitro treatment protocols described earlier. After shape restoration, the
eyes were subjected to high IOP for 23 hours.
RESULTS
Shape Restoration
Initially, the enucleated eyes had a variable shape caused by
postmortem handling (e.g., enucleation, shipping, and removal
of fatty tissue) while their IOP was 0. Applying an IOP near the
physiological level (low IOP, 22 mm Hg) restored the shape of
the globe (Fig. 2). The 11 rabbit kit eyes used in the low (n 
5)- and high (n  6)-pressure creep experiments all received
the same preparation before loading (intact epithelium, no
treatment). One eye was excluded from the analysis because
there was no photograph preceding the application of low
pressure. The rate of change in CP was computed from the
average change over a given 15-minute time interval. During
the first 15 minutes of low pressure, the changes in each ocular
dimension (Fig. 1) were rapid and highly variable (for example,
the corneal perimeter CP increased at a rate of 0.044  0.020
mm/min, n  10). In the next 15 minutes, the changes were
slower on average (0.012 0.016 mm/min for CP, n 10) but
still variable, which can be seen from the individual traces of
CP for each eye (Fig. 2, open symbols). In the next 15 minutes,
the eyes had stabilized, showing much smaller shape changes
with little variability (0.002  0.001 mm/min for CP, n  10).
Similar results were obtained for all ocular dimensions. There-
fore, the ocular dimensions of eyes after 1 hour at low IOP
were taken to represent complete shape restoration (Table 1).
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Creep
Nominal creep was measured with respect to the restored
shape after 1 hour at low IOP (defined as t  0). Although
images were acquired at 15-minute intervals, measurements
are shown at eight selected time points for clarity (0, 1, 3, 7,
11, 15, 19, and 23 hours, Figs. 3, 4).
Low versus High Pressure. Rabbit kit eyes that were
subjected to low IOP for 23 hours showed negligible expan-
sion of the sclera (SP, ED, and SL change 1.2%; Fig. 3, left
column, open symbols), but did exhibit small increases in CP
and axial protrusion (CL; Fig. 4, left column, open symbols).
Changes in CD were consistently less than those in CP and CL,
in accordance with anchoring cornea at the limbus to the
stiffer sclera. The changes in CP, CD, and CL showed strain-
hardening character, approaching plateau values. High IOP
induced significantly greater expansion than low IOP. Creep
was significant for both the sclera (Fig. 3, left, filled versus
open symbols) and the cornea (Fig. 4), increasing linearly from
7 to 23 hours.
Adult versus Kit Eyes. The initial size of the adult rabbit
eyes was 50% larger than that of the kit eyes (Table 1). The
adult eyes expanded under high pressure, but significantly less
than the kit eyes under the same conditions (Figs. 3, 4, middle).
The sclera expanded less than the cornea, as was seen in the kit
eyes (compare scales of Figs. 3, 4). Beyond 7 hours, negligible
further creep occurred in the sclera of the adult eyes (Fig. 3,
middle), which was also manifested in the corneal diameter
remaining fixed for t  7 hours (Fig. 4, middle). Therefore, the
difference in scleral deformation between the kit and adult
eyes increased significantly for these parameters (SP, ED, SL,
and CD) between 7 and 24 hours. The cornea of the adult eyes
continued to creep for the duration of the experiment (both
CP and CL increased steadily, Fig. 4). Due to the constraint at
the limbus, the protrusion of the cornea CL was exaggerated
relative to the increase in CP. Nevertheless, the total deforma-
tion of the cornea in the adult eyes was significantly less than
that in the kit eyes (roughly one third, based on CP at 23
hours).
Riboflavin/UVA versus Negative and Positive Con-
trols. During high-pressure creep, negative control eyes (epi-
thelium removed, dextran drops, and irradiated with UVA
light) expanded in a fashion similar to the untreated kit eyes
with intact epithelium (Figs. 3, 4, compare the dextran control
in the right column to the kit eyes in the middle column).
Treatment of the cornea with riboflavin/UVA significantly re-
duced the expansion of the cornea: the ocular dimensions CP,
CD, and CL only expanded2% after 23 hours, compared with
11% to 16% in the control corneas. As expected, treatment of
the cornea had little effect on the sclera (SP and SL expanded
nearly identically to the control corneas, whereas ED in the
riboflavin-treated eyes expanded less than in the control eyes).
Treatment of the entire globe with glyceraldehyde cross-
linked both the cornea and sclera, causing visible changes in
color as well as mechanical stiffening that was even observable
by hand. Expansion along every ocular dimension was signifi-
cantly reduced relative to dextran control specimens. Even
after 23 hours, expansion was indistinguishable from 0 for all
ocular dimensions. Negative averages do not necessarily indi-
cate shrinkage of the eyes, as the uncertainty does not permit
distinction from no expansion (Table 2). For the cornea, the
difference between the positive control (glyceraldehyde
treated) and the riboflavin treatment is small (2%) but statis-
tically significant (Fig. 4, open circles).
DISCUSSION
We have developed a quantitative method of characterizing
mechanical stability of the cornea and sclera in vitro that
minimizes tissue damage during specimen preparation and
mounting and retains the loading geometry that occurs in vivo.
Digital imaging enables intact globe expansion measure-
ments22 to be performed without mechanically constraining
the globe20 or attaching a strain gauge.23 The present method
incorporates desirable features of prior experimental methods,
using image analysis to achieve sensitive, noncontact measure-
ment of globe dimensions22 and controlling the environment
around the eye to minimize changes in hydration during mea-
surement.20 The measured parameters have correlates in vivo
(corneal and scleral length are directly related to axial length)28
and in vitro (corneal and scleral perimeters are related to
extension measured in tensile tests). The intact globe expan-
sion method enables sensitive discrimination between speci-
FIGURE 2. CP (lines and open symbols, left axis) and its rate of
change (filled bars, right axis) measured before and during imposition
of an IOP of 22 mm Hg in 10 kit eyes. The size of the eyes increased
after the transition from no pressure to low pressure. The rate of
change was greatest during the first 15 minutes. Most changes oc-
curred within the first 30 minutes of shape restoration. Results for CP
were exemplary of all globe dimensions during the first hour of low
pressure.
TABLE 1. Dimensions of the Eye Measured after 1 Hour of Low IOP
n SP ED SL CP CD CL
Kit, 2 wk 11 28.5  1.3 13.8  0.7 9.6  0.4 12.2  1.1 10.1  0.8 3.0  0.4
Adult, 6 mo 10 40.3  1.3 20.6  0.6 13.6  0.6 20.0  0.8 16.1  0.5 5.1  0.4
Ocular dimensions of the eye measured after 1 hour at 22 mm Hg (average  SD in millimeters).
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mens at slight strains and low strain rates. Application of this
method reveals that rabbit kit eyes can serve as a model tissue
mimicking the poor mechanical integrity characteristic of ker-
atoconus and degenerative myopia. Treating this weak tissue
with riboflavin/UVA or with glyceraldehyde strengthens it be-
yond the level of normal adult tissue.
We suggest that GEM with immature tissue could be used to
optimize treatment parameters in vitro (e.g., to meet or exceed
a benchmark in strength, such as the change produced by
riboflavin/UVA treatment or the strength of normal tissue). The
ability of GEM to discriminate between different treatments in
small samples makes it an attractive tool for comparative stud-
ies of efficacy of collagen cross-linking.
Such in vitro studies could guide the selection of drug and
irradiation combinations to advance to in vivo experiments.
Furthermore, GEM may prove useful in conjunction with in
FIGURE 3. Change of scleral dimen-
sions with time (t 0 at the end of the
restoration period). Left: rabbit kit eyes
subjected to low (22 mm Hg) and high
(85 mm Hg) pressures; *the first time
point at which the two differed signif-
icantly (P  0.05, Student’s t-test). At
low pressure, the rabbit kit sclera re-
mained stable; at high pressure, the
sclera expanded. Middle, rabbit kit
eyes and adult rabbit eyes subjected to
high pressures (85 mm Hg); *the first
time point at which the two differed
significantly. The sclera of kit eye ex-
panded much more than that of the
adult eye. Right: rabbit kit eyes sub-
jected to high pressure after treatment.
Dextran control specimens expanded
similarly to untreated kit eyes. Ribofla-
vin/UVA (Rib/UVA) treatment was in-
tentionally localized to the cornea, and
so it had little effect on scleral expan-
sion. Glyceraldehyde-treated eyes re-
sisted expansion. R, the first point at
which the difference between ribofla-
vin/UVA treatment and the dextran
control is statistically significant; G, the
first point of significant difference be-
tween glyceraldehyde treatment and
the control; and T, the first point of
significant difference between the two
treatments.
FIGURE 4. Change of corneal dimen-
sions with time (t  0 at the end of
the restoration period). Left: rabbit
kit eyes subjected to low (22 mm Hg)
and high (85 mm Hg) pressures; *the
first time point at which the two dif-
fered significantly. The cornea was
more susceptible to creep than was
the sclera (compare to scaling of Fig.
3). The kit cornea expanded to
nearly a plateau level at low pres-
sures; at high pressure, it expanded
continuously. Middle: kit and adult
rabbit eyes subjected to high pres-
sures (85 mm Hg); *the first time
point at which the two differed sig-
nificantly. The cornea of the adult
eye resisted expansion compared to
that of the kit eye. Right: rabbit kit
corneas subjected to high pressure
after treatment. Dextran controls ex-
panded similarly to untreated kit
eyes. Rib/UVA-treated corneas re-
sisted corneal expansion. Glyceralde-
hyde-treated eyes resisted any expan-
sion. Asterisk and R, G, and T:
significant differences as described in
Figure 3.
3124 Mattson et al. IOVS, June 2010, Vol. 51, No. 6
vivo studies, providing a method of evaluating differences in
mechanical stability between treated and fellow globes that
were treated in vivo, then characterized postmortem. It is not
intended to replace in vivo studies.
One challenge facing those conducting in vitro studies is
the change in the hydration state of the tissue during transpor-
tation, dissection, and experimental measurement. Limited
pachymetry readings on untreated kit eyes with intact epithe-
lium showed that the corneas did swell during shipment in
saline (received corneal thickness was 530  50 m), as
expected based on prior literature.29 During shape restoration,
the corneal thickness of untreated eyes decreased to 390  20
m (in vivo thickness is 300 m).30 During expansion at
high pressure, thickness measurements were not obtained;
future experiments can be designed to facilitate thickness
measurements without disturbing the eyes. However, there
was no indication of swelling during the intact globe expan-
sion (e.g., corneal transparency did not significantly change
over the 23 hours of the experiment). Nor was there any
indication that swelling markedly changed the tissue mechan-
ical response (e.g., creep rates were indistinguishable for un-
treated kit eyes with intact epithelium and dextran controls
that were de-epithelialized and given drops of 20% dextran for
1 hour). Therefore, we attribute the observed changes in me-
chanical stability to collagen cross-linking. Future experiments
could evaluate the possible effects of swelling by modifying
tissue handling and the environment (e.g., examine eyes im-
mediately after enucleation and replace DPBS with corneal
storage medium).
Shape Restoration
Precise characterization of tissue mechanics requires repeat-
able techniques that measure changes from a well-defined
initial state. The biomechanics literature describes a plethora of
techniques for establishing the initial conditions (e.g., applying
a cyclic load or deformation, deforming the tissue until a
selected stress is recorded or applying a small stress until
deformation ceases). Although any of these methods could be
implemented with GEM, we chose to restore in vivo shape in
a simple manner. When the eye is enucleated, there is a drop
in IOP, and handling the eyes without the stabilization pro-
vided by the IOP causes each specimen to have a perturbed
shape, different from its in vivo shape. Using GEM with an
intact globe allows its natural constraints to be used in restor-
ing a shape analogous to that in vivo. The protocol we used is
based on physiological data (we applied an IOP that is slightly
above the physiological range). The results showed very good
reproducibility, perhaps as a consequence of using an IOP that
was high enough to eliminate any variations between eyes that
had different IOPs in vivo, while not producing a gross con-
tinual creep. The time necessary for each eye to reach a stable
shape was found to be less than 30 minutes for all 11 eyes
examined (Fig. 2). After reaching a stable shape, the sclera did
not undergo statistically significant creep (Fig. 3, left column)
and the cornea exhibited very gradual creep (strain at0.02%/
min; Fig. 4, left column). If the shape restoration period is too
short, then the initial creep measurements will show artificially
high creep rates with larger variability. Therefore, we chose to
allow more than 30 minutes, to ensure minimal variability in
the initial condition while keeping the shape restoration time
short enough that negligible creep had time to occur (hence, a
1-hour shape-restoration period was chosen).
Creep
Mechanical stability is of obvious clinical importance. In vivo,
the eye sustains an IOP while maintaining its shape. Creep tests
permit the study of how well the tissue can resist deformation
under a constant IOP. In disease states associated with elevated
pressure or with weakened tissue, the eye can become suscep-
tible to distension. This inspired our decision to examine an
intact globe using a creep test at a constant IOP instead of
injecting specified volumes of liquid22 or ramping up the pres-
sure.19,23 Rather than forcing the tissue to undergo a specific
extent of deformation (e.g., a step strain imposed by injection
of a known volume of liquid), we probed the ability of the
tissue to resist deformation. Instead of imposing a brief win-
dow of time at each incrementally higher pressure in a contin-
uous ramp, we allowed many hours of observation at a fixed
IOP, to discover whether the tissue deforms continuously or
reaches a steady shape. Treatments aimed at making the tissue
stronger could be evaluated by using other mechanical meth-
ods, but creep tests are particularly appropriate for revealing
whether a specific treatment can actually prevent expansion of
the tissue when challenged at a particular IOP.
The IOP that the cornea can withstand without ongoing
deformation is lower than that which the sclera can withstand
(Figs. 3, 4), in accordance with current knowledge of corneal
and scleral mechanical properties.19,22 Although the hydration
state of the tissue may shift these thresholds, a clear trend is
evident: At low IOP only the cornea continues to creep,
whereas at high IOP, both the cornea and the sclera undergo
creep, with expansion increasing linearly with time. For the
purpose of discriminating between different proposed colla-
gen cross-linking conditions, it is useful to find an imposed IOP
that produces nominal strain that is substantially greater than
the experimental uncertainty. Simply stated, if the control eyes
do not deform, then the treated tissues cannot be distinguished
from the control. Comparison of low and high IOP illustrates
the criteria for selecting a suitable IOP to use for comparative
evaluation of treatments: Low IOP did not induce adequate
deformation of the control specimens (Figs. 3, 4, left, open
symbols), whereas high IOP applied to the kit cornea induced
a deformation that was approximately five times greater than
the SD of the data (Fig. 4, filled squares).
TABLE 2. Percentage Change in Ocular Dimension after 23 Hours
n SP ED SL CP CD CL
Kit low IOP* 5 0.5  1.0 1.1  1.0 0.02  1.4 5.3  3.2 2.0  2.9 10.8  4.6
Kit high IOP† 6 6.7  2.2 8.9  2.8 6.3  1.4 13.9  3.0 10.8  2.9 20.4  5.1
Adult high IOP† 8 1.2  1.3 1.2  0.8 1.6  1.9 4.5  1.9 2.7  1.8 7.5  4.4
Dextran control† 5 5.2  1.9 5.7  1.7 6.2  2.0 12.2  3.5 10.6  3.8 16.0  4.5
Riboflavin/UVA† 5 4.1  2.7 2.8  1.6 4.4  3.1 1.7  2.2 2.0  2.5 1.7  3.1
Glyceraldehyde† 6 0.7  0.5 0.3  0.3 0.9  0.6 0.3  0.9 0.2  0.9 0.9  1.1
Change in ocular dimension (average  SD) was calculated as the percentage increase in the size of the eye during the 23 hours after shape
restoration.
* IOP  22 mm Hg.
† IOP  85 mm Hg.
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At the same time, the magnitude of the strain at which the
experiment achieves this level of confidence should be small
enough to be physiologically relevant. Therefore, methods for
comparative evaluation of corneal cross-linking protocols must
have small experimental uncertainty. Examination of the re-
sults in kit corneas subjected to high IOP showed that a
nominal strain of 6% was sufficient (SD less than one fifth of the
mean) and that consistent results were obtained over the range
from 6% to 20% nominal strain. Further reduction in the un-
certainty of GEM may be possible by reducing animal-to-animal
variability. The most obvious direction to pursue is pair-wise
comparison of eyes from the same animal. Analysis of the
instrumental uncertainty shows that little can be gained by
improved image acquisition or processing until other sources
of variability are reduced by an order of magnitude.
A final consideration illustrated by the response to high IOP
is that it generates a significant degree of expansion within 24
hours without rupturing the eyes. The experiment is short
enough that the tissue does not significantly deteriorate, yet
long enough that the deformation occurs gradually (0.01%/
min). It is hoped that choosing the in vitro IOP in this way will
allow the experiment to reveal information pertinent to pre-
vention of progressive changes in corneal and scleral shape
that occur at normal IOP over much longer periods in diseases
such as keratoconus and degenerative myopia.
In addition to selection of the appropriate IOP to impose in
vitro, we considered the choice of tissue to use as a model.
Andreassen et al.15 and others16,17 have shown that the cornea
and sclera in keratoconus and myopia have reduced biome-
chanical stability compared with healthy tissue. In in vitro
studies of the mechanical changes induced by prospective
treatments for these ocular diseases, normal adult porcine eyes
have been used primarily, with human donor tissue used in a
few (Spoerl E et al. IOVS 1999;40:ARVO Abstract 1800).24,25 In
a study of in vivo treatments and evaluation of their effects,
postmortem mature rabbits with healthy ocular tissue were
used.31 It is well known that mature, healthy tissue undergoes
considerable enzymatic cross-linking of collagen, which in-
creases the strength of the cornea and sclera. Collagen in
young animals does not have the full complement of cross-links
present in mature collagen.32 There is clinical evidence that
immature ocular tissue is more susceptible to deformation:
Marked axial enlargement of the globe occurs in infantile
glaucoma; for example, although no such changes are noted in
adult forms.33 Therefore, we propose that tissues in which this
maturation process is incomplete serve as a model that is more
representative of weaker, diseased tissue. The reasoning is
distinct from in vivo young animal models of myopia that
exploit the neurophysiological feedback system to remodel the
tissue during development and emmetropization.16,17,34
Rather, the low mechanical strength of the young tissue mim-
ics the weakness found in diseased tissue that is addressed by
therapeutic collagen cross-linking.
The present comparison of tissues from 2- to 3-week-old
rabbit kits and adult rabbits (6 mo) indicates significantly
greater expansion of immature globes (Figs. 3, 4, middle col-
umns). This difference cannot be explained simply by the
difference in size of the globes. For a given imposed IOP, the
stress in the tissue scaled linearly with a characteristic radial
dimension and inversely with a characteristic tissue thickness.
We found that the ratio of the globe radial size and the tissue
thickness was very similar in 2- to 3-week-old and adult rabbits
(within 5%–10%, depending on the position chosen for com-
paring the tissue thickness). The observed differences (300%
for the cornea and up to 700% for the sclera) were much
greater, indicating that the kit eyes are more distensible than
the adult eyes. Therefore, we regard kit eyes as the better
model of weak tissue susceptible to expansion.
Comparative Evaluation of Treatments
The clinical significance of riboflavin/UVA treatment is becom-
ing increasingly evident, motivating the development of fur-
ther refinements to reduce the treatment time (1 hour per
eye), to reduce toxicity to keratocytes,35 to enable treatment of
thin corneas without damaging the endothelium,36 and to
enable collagen cross-linking of the sclera without retinal tox-
icity.26 Therefore, researchers are modifying the established
riboflavin/UVA protocol (e.g., reducing light intensity, irradia-
tion time, and concentration of riboflavin) and examining al-
ternative agents (e.g., glyceraldehyde).9,10 In the treatment
optimization process, GEM can be used for in vitro evaluation
of the relative efficacy of different treatments. The present
experiments readily distinguished between control corneas
and corneas treated using the riboflavin/UVA procedure (Fig.
4, right column). Groups of four samples were sufficient to
achieve statistically significant differences between riboflavin/
UVA-treated and control eyes, based on a t-test tolerating a 5%
chance of a false-affirmative and a 5% chance of a false-negative
conclusion (statistical analysis program, G*Power).37
Clinically, interesting comparisons would be those between
diseased tissue that has been strengthened and normal tissue
that is stable. As discussed, we chose kit eyes as a model of
weakened tissue compared with stable adult eyes. Ribofla-
vin/UVA treatment strengthened the weak kit cornea well
beyond the normal adult rabbit cornea (Fig. 4, middle, right
columns). The clinical success of the riboflavin/UVA corneal
collagen cross-linking technique as a treatment for keratoconus
indicates that treatment achieves stability; however, a milder
treatment might be sufficient based on our expansion results in
rabbits, which indicate that riboflavin/UVA treatment may
strengthen tissue beyond normal levels. It would be interesting
to study the efficacy of milder treatments. Furthermore, the
alternative treatment with glyceraldehyde demonstrated
greater stability than the riboflavin/UVA treatment.
In evaluating small differences between optimized treat-
ments the testing method must be subject to little variability
and must be sensitive. The variability of GEM is minimized by
eliminating the need to cut tissue and the variability due to
clamping or securing the tissue and by providing a method of
establishing the initial size of the eye. The uncertainty of the
measurement technique is well below the animal-to-animal
variability. Even with the observed animal-to-animal variability,
we have demonstrated that the sensitivity of this method al-
lows for discrimination between treatments that change the
ultimate strain (24 hours) by as little as 2%. To further improve
sensitivity, pairs of fellow eyes given different treatments can
be compared. Alternatively, increasing the IOP may create
larger distension of strengthened tissue, allowing greater dis-
crimination among treatments. Together, these techniques
may provide the capability of distinguishing between treat-
ments of different concentration, exposure time, and light
intensity, for example. Finally, rabbit kit tissue affords greater
sensitivity to treatment than does adult tissue, which has been
used in prior studies of corneal and scleral cross-linking. The
inherent stability of normal adult tissue obscures the incremen-
tal change in strength due to treatment. Indeed, a weak tissue
model such as kit eyes may prove useful in conjunction with
other mechanical testing methods as well.
In relation to myopia treatments, we note that glyceralde-
hyde cross-linking prevents expansion of the entire eye (mea-
sured changes are indistinguishable from 0% expansion). The
intact globe expansion apparatus is capable of measuring dif-
ferences in scleral expansion (Fig. 3, right column), with sen-
sitivity similar to that for corneal expansion. Further experi-
ments and characterization of treatments on the sclera could
provide insight for development of future treatments for de-
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generative myopia (e.g., glyceraldehyde and nitroalcohols)9–11
or glaucoma.12
CONCLUSIONS
In this study, we were able to demonstrate a quantitative
method of examining the mechanical behavior of the cornea
and sclera while maintaining an intact geometry similar to that
of the in vivo state. Despite their nonuniform thickness, non-
uniform curvature, and nonuniform mechanical properties, the
cornea and sclera in an intact globe geometry exhibited repro-
ducible nominal creep rates under the influence of an imposed
IOP. This characteristic of the intact globe makes it well suited
to quantitative characterization of the effect of changes in
mechanical stability, such as the effect of a prescribed collagen
cross-linking procedure. Consequently, the intact GEM affords
quantitative evaluation of treatments when applied to treated
and control specimens from animals of a given species and age.
We validated a model of weak eye tissue and used this model
to illustrate head-to-head treatment comparisons. The results
show that statistically significant discrimination between dif-
ferent treatments was achieved with a small number of speci-
mens.
The apparatus can be readily adapted for other research
objectives. In addition to probing the mechanical integrity of
the ocular coat at constant IOP, this method is designed to
accommodate a variety of tests to examine dynamic and elastic
properties of the eye (e.g., steps or ramps in IOP). Measure-
ments are performed while the tissue is immersed in a bath,
enabling studies of the mechanical behavior of tissue as a
function of the chemical and physical environment, such as
pH, temperature, osmolarity, and concentration of various
chemical species (e.g., distinct salts). The method permits
researchers to use their choice of bath fluid (e.g., if eyes were
used immediately after enucleation, mineral oil might be used
if some deswelling is acceptable).20 Mechanical behavior as a
function of disease state could be studied by applying GEM to
eyes in animal models (myopia: guinea pig,34 chick,16 and tree
shrew16,17; glaucoma: mouse/rat).38 Furthermore, the method
could be extended by incorporating multiple cameras, particle
tracking, pachymetry, ultrasound biometry, and/or optical co-
herence tomography to reconstruct the three-dimensional sur-
face of the eye and monitor thickness as the eye responds to an
imposed IOP.
Despite the diversity of possible applications of this
method, the intact globe expansion apparatus is relatively
simple and provides reproducible results. Inexpensive compo-
nents allow for the construction of multiple setups in the
laboratory and minimize the barrier for other researchers wish-
ing to study intact globes. Within the field of ocular biome-
chanics, access to an inexpensive apparatus to characterize the
mechanical integrity of the cornea and sclera may foster studies
of the eye’s tissue mechanics and facilitate development, char-
acterization, and in vitro validation of treatments that therapeu-
tically modify the mechanical properties of these tissues.
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